ATA579280A - Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate - Google Patents

Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate

Info

Publication number
ATA579280A
ATA579280A AT0579280A AT579280A ATA579280A AT A579280 A ATA579280 A AT A579280A AT 0579280 A AT0579280 A AT 0579280A AT 579280 A AT579280 A AT 579280A AT A579280 A ATA579280 A AT A579280A
Authority
AT
Austria
Prior art keywords
hydroxyprostansaeur
unsaturated
derivatives
producing new
producing
Prior art date
Application number
AT0579280A
Other languages
English (en)
Other versions
AT379144B (de
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ATA579280A publication Critical patent/ATA579280A/de
Application granted granted Critical
Publication of AT379144B publication Critical patent/AT379144B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/80Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
AT0579280A 1979-11-28 1980-11-27 Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate AT379144B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/098,290 US4271314A (en) 1979-11-28 1979-11-28 4,5-Unsaturated prostanoic acid derivatives

Publications (2)

Publication Number Publication Date
ATA579280A true ATA579280A (de) 1985-04-15
AT379144B AT379144B (de) 1985-11-25

Family

ID=22268646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0579280A AT379144B (de) 1979-11-28 1980-11-27 Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate

Country Status (23)

Country Link
US (1) US4271314A (de)
JP (1) JPS5699457A (de)
AT (1) AT379144B (de)
AU (1) AU539192B2 (de)
BE (1) BE886370A (de)
CA (1) CA1192903A (de)
CH (1) CH646147A5 (de)
DE (1) DE3044794A1 (de)
DK (2) DK504680A (de)
ES (2) ES497260A0 (de)
FI (1) FI71552C (de)
FR (1) FR2473516A1 (de)
GB (1) GB2065117B (de)
GR (1) GR72283B (de)
IE (1) IE50574B1 (de)
IL (1) IL61575A (de)
IT (1) IT1207155B (de)
NL (1) NL191386C (de)
NO (1) NO155289C (de)
NZ (1) NZ195666A (de)
PT (1) PT72129B (de)
SE (1) SE436873B (de)
ZA (1) ZA807415B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529811A (en) * 1981-03-02 1985-07-16 G. D. Searle & Co. Process for isolating organic compounds and lithium salt complexes useful in said process
US4312994A (en) * 1981-03-25 1982-01-26 G. D. Searle & Co. α Chain dienic prostanoic acid derivatives
US4499296A (en) * 1983-11-14 1985-02-12 G. D. Searle & Co. Omega cycloalkyl prostaglandins
US4754059A (en) * 1984-11-07 1988-06-28 G. D. Searle & Co. Omega cycloalkyl prostaglandins
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds
US5011958A (en) * 1987-06-08 1991-04-30 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4785124A (en) * 1987-06-08 1988-11-15 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4777275A (en) * 1987-06-09 1988-10-11 G. D. Searle & Co. Process of preparing higher order cuprate complexes
US5191109A (en) * 1990-02-02 1993-03-02 Sumitomo Chemical Company, Limited Process for preparing optically active cyclopentenones
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
KR20020067594A (ko) 2000-01-05 2002-08-22 오노 야꾸힝 고교 가부시키가이샤 5-티아-ω-치환 페닐-프로스타글란딘 E-알콜, 이들의제조 방법 및 이들을 유효 성분으로서 함유하는 약제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965143A (en) * 1974-03-26 1976-06-22 G. D. Searle & Co. 16-Oxygenated prostanoic acid derivatives
US4028419A (en) * 1976-01-08 1977-06-07 The Upjoin Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds
GB1595118A (en) * 1977-05-31 1981-08-05 Sumitomo Chemical Co Prostadienoic acids processes for producing them and compositions containing them

Also Published As

Publication number Publication date
AU6476680A (en) 1981-07-02
FI71552B (fi) 1986-10-10
IL61575A0 (en) 1980-12-31
AU539192B2 (en) 1984-09-13
NZ195666A (en) 1982-12-21
ES8204418A1 (es) 1982-04-01
US4271314A (en) 1981-06-02
PT72129B (en) 1981-09-29
NL8006473A (nl) 1981-07-01
NO155289B (no) 1986-12-01
DE3044794C2 (de) 1990-02-15
DE3044794A1 (de) 1981-08-27
ES507577A0 (es) 1982-10-01
ES497260A0 (es) 1982-04-01
CH646147A5 (de) 1984-11-15
NO155289C (no) 1987-03-11
FI71552C (fi) 1987-01-19
GB2065117B (en) 1984-09-05
NO803592L (no) 1981-05-29
DK162281C (da) 1992-03-16
IE802471L (en) 1981-05-28
NL191386B (nl) 1995-02-01
IL61575A (en) 1984-05-31
IE50574B1 (en) 1986-05-14
DK504680A (da) 1981-05-29
JPS6366832B2 (de) 1988-12-22
FI803685L (fi) 1981-05-29
IT8050259A0 (it) 1980-11-27
IT1207155B (it) 1989-05-17
CA1192903A (en) 1985-09-03
DK162281B (da) 1991-10-07
ZA807415B (en) 1982-07-28
ES8300089A1 (es) 1982-10-01
PT72129A (en) 1980-12-01
SE436873B (sv) 1985-01-28
GR72283B (de) 1983-10-14
DK613487A (da) 1987-11-23
DK613487D0 (da) 1987-11-23
FR2473516B1 (de) 1983-07-29
FR2473516A1 (fr) 1981-07-17
SE8008300L (sv) 1981-05-29
JPS5699457A (en) 1981-08-10
AT379144B (de) 1985-11-25
GB2065117A (en) 1981-06-24
NL191386C (nl) 1995-07-03
BE886370A (fr) 1981-05-27

Similar Documents

Publication Publication Date Title
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA179380A (de) Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-athyl-7,13,14trihydroxy-3,5,7,9,12,14-hexa- methyloxacyclopentadecan-2-ons- und dessen derivaten
AT371817B (de) Verfahren zur herstellung neuer ergolinderivate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
AT361929B (de) Verfahren zur herstellung neuer 5,11-dihydro- -6h-pyrido(2,3-b)(1,4) benzodiazepin-6-on- -derivate und ihrer salze
AT376220B (de) Verfahren zur herstellung neuer 1,4-dihydropyridinderivate
AT355041B (de) Verfahren zur herstellung neuer n,n'-thio-bis- oximcarbamate
AT379144B (de) Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
LU82242A1 (de) Verfahren zur herstellung 2',6'-dialkyl-n-(alkoxymethyl)-2-chloracetaniliden
PT71116A (de) Verfahren zur herstellung neuer cyclobutandicarbonsaureimide
AT355036B (de) Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one
AT362389B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
AT357516B (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
AT376683B (de) Verfahren zur herstellung neuer 1-oxa-4-aza-2,6- disilacyclohexane
AT365606B (de) Verfahren zur herstellung neuer 1,6-anhydro-beta- d-hexopyranosederivate
ATA421180A (de) Verfahren zur herstellung neuer 1,6-anhydro-beta-d-hexopyranosederivate
AT370085B (de) Verfahren zur herstellung neuer aminobenzoesaeure- derivaten
ATA62282A (de) Verfahren zur herstellung neuer amino-2,1,3-benzo-thiadiazol- und -benzoxadiazolderivate
ATA227183A (de) Verfahren zur herstellung neuer 2-hydroxymethyl -3,4,5-trihydroxypiperidinderivate
ATA533181A (de) Verfahren zur herstellung neuer 2-hydroxymethyl -3,4,5-trihydroxypiperidinderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee